Skip to content
Screener

Guardian Pharmacy Services GRDN Return on equity

Return on equity at other companies

CVS Health logo
CVS HealthCVS
6.2%+0.3pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
16.9%—
Omnicell logo
OmnicellOMCL
1.6%+1.1pp
Cencora logo
CencoraCOR
130.6%-99.8pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-612.1%—
PACS Group logo
PACS GroupPACS
27.3%+15.8pp

Other financials

Income statement

See full
Revenue$351.8M+2.2%
Gross profit$80.0M+17.5%
Operating income$20.6M+64.1%
Net income$21.9M+142%
EPS (diluted)$0.34+143%

Balance sheet

See full
Cash & equivalents$89.8M+377%
Total debt$35.2M+4.6%
Total equity$257.6M+43.4%
Total assets$443.6M+24.5%

Cash flow

See full
Operating cash flow$30.0M+50.6%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation

See full
Market cap$2.5B+88.6%
Enterprise value$2.44B+82.4%
P/E37.9×—
P/S1.7×+0.7×

Profitability

See full
Gross margin21.6%+2.0pp
Operating margin5.8%—
Net margin4.5%+2.8pp

Returns & leverage

See full
Debt / equity0.1×-0.1×
Current ratio1.7×+0.5×

Where this comes from

Calculated from Guardian Pharmacy Services’s reported figures.

net income/total stockholders equity=30.1%

Based on trailing twelve months.

The source filing: Guardian Pharmacy Services’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338074

FAQ

What is Guardian Pharmacy Services's return on equity?
Guardian Pharmacy Services (GRDN) reported return on equity of 30.1% in Q2 2026.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about Guardian Pharmacy Services's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude